Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Harley-Davidson Inc (HOG) vs Medtronic PLC (MDT) Price & Performance

Harley-Davidson IncTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Harley-Davidson Inc vs Medtronic PLC — how do they compare? Harley-Davidson Inc trades at $26.75 (market cap $2.80B), while Medtronic PLC trades at $87.69 (market cap $109.38B). The key difference: Medtronic PLC is far larger — about 39.1× Harley-Davidson Inc's market cap, and Medtronic PLC pays the higher dividend (3.37%). Which is the better fit depends on your goals — on Pluang, investors hold Harley-Davidson Inc for 91 Days and Medtronic PLC for 63 Days on average.

HOGMDT
Market Cap
$2.80B$109.38B
Volume
2,093,21655,890,185
Sector
Consumer CyclicalHealth
52-Week High
$28.46$105.35
52-Week Low
$17.19$73.75
Typical Hold Time
91 Days63 Days
Enterprise Value
$3.22B$128.71B
Dividend Yield
2.78%3.37%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Harley-Davidson Inc

Harley-Davidson (HOG) trades at $26.75, down 0.71% on the day, with a bullish technical signal and mixed earnings history. The stock shows attractive valuation ratios, including a P/E of 14.97 and P/S of 0.72, but faces declining revenue and net income margins. Recent news highlights tariff exposure and a data breach, while analyst consensus is a 'Hold' with a $28.50 price target. Cash flow trends are volatile, with 2025 showing a net inflow of $1.35 billion driven by investing activities.

The outlook for HOG is cautious due to fundamental pressures, including falling profitability and revenue, offset by low valuations and a dividend. Key risks include competitive threats and sensitivity to tariffs. Upside potential exists if the 'Back to the Bricks' strategy revives growth, but investors should weigh margin erosion against valuation support.

Medtronic PLC

Medtronic (MDT) trades at $87.75, up 0.76% on the day, with strong analyst support (60.78% buy ratings) and a $97.80 consensus price target suggesting 11.4% upside. The stock shows consistent earnings beats in recent quarters with Q3 2026 results pending, while technical indicators signal bearish momentum despite oversold RSI readings. Recent positive developments include FDA clearances for new medical technologies and a 49-year dividend growth streak with a current 3.2% yield.

MDT presents a compelling value opportunity with reasonable valuation multiples (P/E 21.06, P/S 2.93) and improving fundamentals, though technical weakness and competitive pressures warrant caution. The company's revenue growth acceleration to $33.54B in 2025 and strong cash flow generation support the dividend sustainability, while debt levels have increased to 31.11% of assets, representing a key monitoring point for investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HOG

No sentiment data available yet.

MDT
53% Buy47% Sell
Avg holding period · 63 Days

Top news

Latest headlines on both assets

About Harley-Davidson Inc

Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.

Read more on HOG →

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT →